Project Oncology®
Project Oncology®
ReachMD
Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
1 seconds Posted Jun 13, 2023 at 4:00 am.
0:00
0:01
Download MP3
Show notes
Guest: Vivek Subbiah, MD

This episode will recap updates from the 2023 ASCO Annual Meeting regarding the abstract on comprehensive genomic profiling for non-small cell lung cancer (NSCLC). Join Dr. Vivek Subbiah, Chief of Early Drug Development at the Sarah Cannon Research Institute in Nashville, Tennessee, to learn more.